GMO TRUST Files DEF 14A for Shareholder Meeting

Gmo Trust DEF 14A Filing Summary
Field	Detail
Company	Gmo Trust
Form Type	DEF 14A
Filed Date	Aug 1, 2025
Risk Level	low
Sentiment	neutral

Sentiment: neutral

Topics: Proxy Statement, Investment Funds, Shareholder Meeting, Corporate Governance, Asset Management, Mutual Funds, SEC Filing

TL;DR

**GMO TRUST's DEF 14A is a routine governance filing, but investors should scrutinize the proposals to ensure their interests are protected in this diverse fund family.**

AI Summary

GMO TRUST, an investment company, filed a DEF 14A on August 1, 2025, outlining its proxy materials for a shareholder meeting scheduled for September 9, 2025. The filing details various investment funds managed by GMO TRUST, including the GMO U.S. Equity Fund, GMO Quality Fund, GMO International Equity Fund, and GMO Emerging Markets Fund, each with multiple share classes such as Class III, Class IV, Class V, Class VI, Class I, and Class R6. While specific revenue and net income figures are not provided in this proxy statement, the document indicates ongoing operations across a broad spectrum of asset classes, from equity to fixed income and allocation strategies. Key business changes include the continued management of specialized funds like the GMO Climate Change Fund and GMO Opportunistic Income Fund, reflecting a diverse strategic outlook. Risks are inherent in the various investment strategies, though this filing primarily focuses on governance and shareholder voting matters rather than detailed financial performance or specific risk mitigation strategies. The strategic outlook emphasizes maintaining a wide array of investment options for shareholders.

Why It Matters

This DEF 14A filing from GMO TRUST is crucial for investors as it sets the stage for key governance decisions at the upcoming September 9, 2025 shareholder meeting. Understanding the proposals within this proxy statement can impact the future direction and management of the various GMO funds, potentially affecting investment performance and shareholder rights. For employees, the stability and strategic choices made by the trust can influence job security and compensation. In a competitive asset management landscape, GMO TRUST's ability to effectively manage its diverse fund offerings, from the GMO Climate Change Fund to the GMO Emerging Country Debt Fund, is vital for retaining customers and market share against rivals like BlackRock and Vanguard.

Risk Assessment

Risk Level: low — The risk level is low because this DEF 14A filing is a standard proxy statement, primarily concerning governance and shareholder voting for the September 9, 2025 meeting. It does not disclose new financial risks or significant operational changes, but rather outlines the framework for ongoing fund management. The document's focus is on procedural matters for GMO TRUST, a well-established entity with SEC File Number 811-04347.

Analyst Insight

Investors should carefully review the specific proposals outlined in this DEF 14A filing before the September 9, 2025 shareholder meeting. Understanding the voting items is critical to exercising shareholder rights and influencing the governance of their GMO TRUST investments. Pay attention to any proposed changes in fund structure or management fees.

Financial Highlights

total Assets: Not Disclosed
total Debt: Not Disclosed

Key Numbers

2025-08-01 — Filing Date (Date the DEF 14A was filed by GMO TRUST)
2025-09-09 — Conformed Period of Report (Date of the shareholder meeting for which the proxy materials are filed)
0000772129 — Central Index Key (CIK) (Unique identifier for GMO TRUST with the SEC)
811-04347 — SEC File Number (Registration number for GMO TRUST as an investment company)
3 — Public Document Count (Number of documents included in this specific SEC filing)
6173467646 — Business Phone (Contact number for GMO TRUST)
1990-09-27 — Date of Name Change (Date GMO CORE TRUST changed its name to GMO TRUST)

Key Players & Entities

GMO TRUST (company) — filer of DEF 14A
SEC (regulator) — regulatory body for DEF 14A
GMO U.S. Equity Fund (company) — investment fund managed by GMO TRUST
GMO Quality Fund (company) — investment fund managed by GMO TRUST
GMO International Equity Fund (company) — investment fund managed by GMO TRUST
GMO Emerging Markets Fund (company) — investment fund managed by GMO TRUST
GMO Climate Change Fund (company) — specialized investment fund managed by GMO TRUST
GMO Opportunistic Income Fund (company) — specialized investment fund managed by GMO TRUST
Boston (location) — business address of GMO TRUST
53 State Street (location) — business address of GMO TRUST

FAQ

What is the purpose of GMO TRUST's DEF 14A filing?

GMO TRUST's DEF 14A filing, submitted on August 1, 2025, serves as a definitive proxy statement to inform shareholders about matters to be voted upon at the upcoming annual meeting scheduled for September 9, 2025. It provides essential information for shareholders to make informed decisions regarding corporate governance and other proposals.

When is the GMO TRUST shareholder meeting scheduled?

The shareholder meeting for GMO TRUST, as indicated in the DEF 14A filing, is scheduled for September 9, 2025. This date is listed as the 'Conformed Period of Report' in the filing details.

What types of funds does GMO TRUST manage according to this filing?

According to the DEF 14A, GMO TRUST manages a diverse range of funds including the GMO U.S. Equity Fund, GMO Quality Fund, GMO International Equity Fund, GMO Emerging Markets Fund, GMO Climate Change Fund, and GMO Opportunistic Income Fund, among many others, each with various share classes.

Where is GMO TRUST's business address located?

GMO TRUST's business address is 53 State Street, Floor 33, Boston, MA 02109. This information is consistently provided in the filing's business and mail address sections.

What is GMO TRUST's Central Index Key (CIK) with the SEC?

GMO TRUST's Central Index Key (CIK) with the SEC is 0000772129. This unique identifier is used by the SEC to track all filings associated with the company.

Has GMO TRUST undergone any name changes?

Yes, GMO TRUST was formerly known as GMO CORE TRUST. The date of this name change was September 27, 1990, as specified in the 'FORMER COMPANY' section of the filing.

What is the significance of the 'Public Document Count' in the filing?

The 'Public Document Count' of 3 indicates that this specific SEC filing package contains three separate documents. This count helps in verifying the completeness of the submission and ensures all intended parts of the filing are present.

How can investors contact GMO TRUST?

Investors can contact GMO TRUST via their business phone number, which is 6173467646. This contact detail is provided in the 'BUSINESS ADDRESS' section of the DEF 14A filing.

Does the DEF 14A filing provide specific financial performance data for GMO TRUST?

No, this DEF 14A filing primarily focuses on proxy materials for a shareholder meeting and corporate governance. It does not provide specific financial performance data such as revenue, net income, or detailed balance sheet figures for GMO TRUST or its individual funds.

What is the state of incorporation for GMO TRUST?

GMO TRUST is incorporated in the state of Massachusetts (MA). This detail is listed under the 'COMPANY DATA' section of the DEF 14A filing.

Risk Factors

Investment Strategy Risks [medium — market]: The various GMO TRUST funds employ diverse investment strategies, including equity, fixed income, and allocation approaches. These strategies inherently carry market risks, such as fluctuations in security prices, interest rates, and currency exchange rates, which can impact fund performance.
Operational and Management Risks [low — operational]: As an investment company, GMO TRUST is subject to operational risks related to its management, administration, and trading activities. Errors in processing, system failures, or inadequate internal controls could lead to financial losses or reputational damage.
Regulatory Compliance [medium — regulatory]: GMO TRUST operates within a highly regulated environment. Changes in securities laws, tax regulations, or other governmental policies could affect the funds' operations, investment strategies, and profitability.

Industry Context

GMO TRUST operates within the asset management industry, a sector characterized by intense competition and evolving investor preferences. The industry is influenced by macroeconomic trends, regulatory changes, and technological advancements. Companies like GMO TRUST focus on offering specialized investment vehicles across various asset classes to attract and retain assets under management.

Regulatory Implications

As a registered investment company, GMO TRUST is subject to extensive regulation by the SEC under the Investment Company Act of 1940 and other securities laws. Compliance with these regulations is critical for maintaining its operating license and investor trust. Changes in regulatory frameworks, such as those related to fees, disclosures, or investment practices, can significantly impact the company's business model.

What Investors Should Do

Review the proxy statement (DEF 14A) carefully before the shareholder meeting on September 9, 2025.
Examine the specific fund offerings and their associated share classes mentioned in the filing.

Key Dates

2025-08-01: DEF 14A Filing — Indicates the release of proxy materials for the upcoming shareholder meeting, providing governance and voting information.
2025-09-09: Shareholder Meeting — The date for which the proxy materials are prepared, where shareholders will vote on important company matters.
1990-09-27: Name Change — GMO CORE TRUST changed its name to GMO TRUST, marking a historical point for the entity.

Glossary

DEF 14A: A filing with the U.S. Securities and Exchange Commission (SEC) that provides detailed information about a company's annual shareholder meeting, including proxy materials. (This is the primary document type filed by GMO TRUST, outlining the agenda and voting matters for its shareholders.)
CIK: Central Index Key, a unique identifier assigned to each entity that files with the SEC. (The CIK (0000772129) uniquely identifies GMO TRUST in SEC filings.)
Share Classes: Different categories of shares within a fund, often distinguished by varying fees, expenses, or distribution policies. (GMO TRUST manages multiple funds, each with several share classes (e.g., Class III, Class IV, Class V, Class VI, Class I, Class R6), offering different investment options to shareholders.)
Proxy Materials: Documents provided to shareholders before a meeting, containing information about the matters to be voted on and recommendations from the board of directors. (The DEF 14A filing contains these materials, which are crucial for shareholders to make informed voting decisions.)

Year-Over-Year Comparison

This DEF 14A filing, dated August 1, 2025, focuses on proxy materials for the September 9, 2025 shareholder meeting. As a proxy statement, it does not typically contain year-over-year financial performance metrics like revenue growth or margin changes. Instead, it details governance matters and the operational structure of various GMO TRUST funds, including their diverse share classes and investment strategies, without providing comparative financial data to a previous filing.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on August 1, 2025 regarding GMO TRUST.

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR